A Look Ahead: Y-mAbs Therapeutics's Earnings Forecast

Y-mAbs Therapeutics (NASDAQ:YMAB) is gearing up to announce its quarterly earnings on Friday, 2025-08-08. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Y-mAbs Therapeutics will report an earnings per share (EPS) of $-0.26.

Y-mAbs Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Performance in Previous Earnings

In the previous earnings release, the company beat EPS by $0.08, leading to a 12.5% drop in the share price the following trading session.

Here's a look at Y-mAbs Therapeutics's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

-0.20

-0.13

-0.16

-0.13

EPS Actual

-0.12

-0.15

-0.16

-0.21

Price Change %

-12.0%

-2.0%

-0.0%

9.0%

Market Performance of Y-mAbs Therapeutics's Stock

Shares of Y-mAbs Therapeutics were trading at $8.52 as of August 06. Over the last 52-week period, shares are down 24.0%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

Analysts' Perspectives on Y-mAbs Therapeutics

For investors, grasping market sentiments ...